TrialJournal of the Chinese Medical Association : JCMA2019

A subanalysis of Taiwanese patients from ODYSSEY South Korea and Taiwan study evaluating the efficacy and safety of alirocumab.

Ting-Hsing Chao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.